Indica Labs Extends Capabilities for Neuroscience with Microglial Activation Analysis Software
Indica Labs, Inc. extends its capabilities in the field of neuroscience by releasing a highly advanced image analysis software package for measuring microglial cell activation in brightfield microscopic images.
Albuquerque, NM (I-Newswire) November 11, 2011 - Indica Labs, Inc. extends its capabilities in the field of Neuroscience by releasing a highly advanced image analysis software package for measuring microglial cell activation in brightfield microscopic images. The software is the first of its kind for providing quantitative, objective, detailed metrics for measuring overall glial cell activation in brain tissue sections.
Microglial cells act as defenders of the brain and their activation level can be an important indicator of brain injury, disease, or toxins. The measurement of microglial cell activation has become a critical aspect of research for many neurological diseases including Alzheimer’s disease, Parkinson’s disease, and autism. Traditionally, these measurements are made by researchers who take on the arduous task of manually characterizing tens of thousands of cells on a single tissue sample.
Indica’s new patent pending software uses advanced image processing algorithms to automatically detect and measure microglial cells and their level of activation. In addition to characterizing microglial cell activation, the software reports a wealth of additional measurements describing glial cell density, cell process length, thickness, and branching. This depth of information is simply unattainable via manual microscopy methods.
Indica Labs, CEO Steven Hashagen remarked:
“We are pleased to be able to announce the release of this groundbreaking software. It took an enormous amount of research and development effort to deliver this highly advanced software for microglial cell analysis. Now these efforts can be leveraged by the talented scientists who are working on the important task of understanding and treating neurological diseases.”
Coupled with the axon quantification software released earlier this year, Indica Labs has moved into the forefront of technology providers for neuroscience research. For more information about these products or any other Indica Labs products, please visit their website at http://indicalab.com/products.html, or contact email@example.com to schedule a complementary demonstration.
About Indica Labs
About Indica Labs, Inc.
Indica Labs provides sophisticated pathology image processing softw More..are for whole-slide tissue analysis. Indica Labs software tools integrate seamlessly into leading digital pathology platforms to provide reproducible and highly quantitative data to pathologists in hospitals, academic medical centers, government research institutions, global pharmaceutical companies, and small biotech firms. For more information, please visit www.indicalab.com. Indica Labs products are intended for research use only.
Indica Labs, Inc. firstname.lastname@example.orgLess..
274 Calle Conejo
Phone : 505 573-5167
Tags:neuroscience pathology activation Digital Pathology tox pathology toxicologic pathology Nucleus Cytoplasm image anal microglia axon
Published in:Science and Research
Published On:November 11, 2011
Print Release:Print Release
If you have questions regarding information in this press release contact the company listed above. I-Newswire.com is a press release service and not the author of this press release.The information that is on or available through this site is for informational purposes only and speaks only as of the particular date or dates of that information. As some companies and PR Agencies submit their press releases once per week,month or quarter, make sure to check the official company website for accurate release dates as our site displays the I-Newswire.com press release distribution date only.We do not guarantee the accuracy or completeness of information on or available through this site, and we are not responsible for or omissions in that information or for actions taken in reliance on that information.